Healthconn Corp. (TPEX:6665)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Health Management Services and Genetic Testing Sales	52.73M	154.94M	-	-	-
Health Management Services and Genetic Testing Sales Growth	-65.97%	-	-	-	-
Medical equipment integration agent	1.08B	1.10B	1.04B	1.01B	906.26M
Medical equipment integration agent Growth	-1.83%	5.11%	3.09%	11.85%	-2.41%
Management of Health Service	-	-	125.07M	214.12M	214.91M
Management of Health Service Growth	-	-	-41.59%	-0.37%	-38.78%
Bio-Safety Testing and Sales	-	-	85.77M	317.56M	241.80M
Bio-Safety Testing and Sales Growth	-	-	-72.99%	31.33%	6.31%
Total	1.13B	1.25B	1.26B	1.55B	1.36B
Total Growth	-9.76%	-0.20%	-18.73%	13.38%	-9.57%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	1.13B	1.24B	1.22B	1.44B	1.23B
Taiwan Growth	-9.07%	1.93%	-15.55%	17.27%	-12.10%
Mainland China	3.64M	13.50M	39.52M	105.02M	134.74M
Mainland China Growth	-73.01%	-65.85%	-62.37%	-22.06%	22.70%
Total	1.13B	1.25B	1.26B	1.55B	1.36B
Total Growth	-9.76%	-0.20%	-18.73%	13.38%	-9.57%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 13, 2026

Data Sources Report a data error